Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Circadian chronotherapy for metastatic liver tumor].
Tanaka K, Yabushita Y, Nakagawa K, Endo I. Tanaka K, et al. Among authors: yabushita y. Nihon Rinsho. 2013 Dec;71(12):2158-64. Nihon Rinsho. 2013. PMID: 24437272 Review. Japanese.
A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma.
Kikuchi Y, Hiroshima Y, Matsuo K, Kawaguchi D, Murakami T, Yabushita Y, Endo I, Taguri M, Koda K, Tanaka K. Kikuchi Y, et al. Among authors: yabushita y. Ann Surg Oncol. 2016 Oct;23(11):3727-3735. doi: 10.1245/s10434-016-5348-3. Epub 2016 Jun 23. Ann Surg Oncol. 2016. PMID: 27338747 Clinical Trial.
[III. Pancreaticoduodenectomy with Arterial Resection and Reconstruction].
Murakami T, Matsuyama R, Mori R, Kumamoto T, Sawada Y, Yabushita Y, Tsuchiya N, Homma Y, Endo I. Murakami T, et al. Among authors: yabushita y. Gan To Kagaku Ryoho. 2017 Oct;44(10):849-853. Gan To Kagaku Ryoho. 2017. PMID: 29066678 Japanese. No abstract available.
Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study.
Matsuyama R, Morioka D, Mori R, Hiratani S, Yabushita Y, Ota Y, Kumamoto T, Taniguchi K, Endo I. Matsuyama R, et al. Among authors: yabushita y. Cancer Chemother Pharmacol. 2018 May;81(5):949-955. doi: 10.1007/s00280-018-3566-z. Epub 2018 Mar 28. Cancer Chemother Pharmacol. 2018. PMID: 29594362
[III. Resection Margins and R1 Resection in Pancreatic Cancer].
Homma Y, Matsuyama R, Kumamoto N, Yabushita Y, Endo I. Homma Y, et al. Among authors: yabushita y. Gan To Kagaku Ryoho. 2018 Oct;45(10):1428-1430. Gan To Kagaku Ryoho. 2018. PMID: 30382038 Japanese. No abstract available.
62 results